Saba Capital sells ECAT shares in February trades
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of ECAT common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of ECAT common stock. On February 12, 2026 it sold 234,005 shares at $15.47 per share, followed by 50,600 shares at $15.22 per share on February 13, 2026.
These transactions were reported as indirect ownership. After the February 13, 2026 sale, Saba Capital Management, L.P. reported beneficial ownership of 23,903,647 ECAT common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 50,600 | $15.22 | $770K |
| Sale | Common Stock | 234,005 | $15.47 | $3.62M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Saba Capital report for ECAT?
What is Saba Capital’s reported ECAT ownership after these Form 4 sales?
Is Saba Capital considered a 10% owner of ECAT in this filing?
Were Saba Capital’s ECAT transactions direct or indirect holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.